Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Theratechnologies (TH.TO)

Theratechnologies (TH.TO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 425,354
  • Shares Outstanding, K 94,945
  • Annual Sales, $ 66,053 K
  • Annual Income, $ -22,667 K
  • 60-Month Beta 1.90
  • Price/Sales 4.41
  • Price/Cash Flow N/A
  • Price/Book 9.48
Trade TH.TO with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.30
  • Most Recent Earnings -0.07 on 05/31/21
  • Next Earnings Date 10/21/21
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

    TSX Drug Specialty & Generic

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 08/31/21
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -0.12
  • Growth Rate Est. (year over year) +832,600.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.28 +4.67%
on 08/23/21
4.77 -6.08%
on 09/14/21
+0.20 (+4.67%)
since 08/20/21
3-Month
4.00 +12.00%
on 08/20/21
4.85 -7.63%
on 07/06/21
-0.10 (-2.18%)
since 06/18/21
52-Week
2.43 +84.36%
on 10/30/20
5.34 -16.10%
on 04/13/21
+0.99 (+28.37%)
since 09/18/20

Most Recent Stories

More News
Theratechnologies to Present at the Cantor Fitzgerald Global Healthcare Conference on September 29, 2021

Theratechnologies Inc. (Theratechnologies) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, today announced that Paul Levesque,...

TH.TO : 4.48 (-2.82%)
THTX : 3.52 (-2.49%)
Theratechnologies Announces Publication of TH1902 Preclinical Data in Peer-Reviewed Journal, Cancer Science

Theratechnologies, Inc. (Theratechnologies, or Company) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, announced today the...

THERF : 3.8000 (+4.68%)
TH.TO : 4.48 (-2.82%)
THTX : 3.52 (-2.49%)
Theratechnologies to Present at the Canaccord Genuity 41st Annual Growth Conference

Theratechnologies Inc. (Theratechnologies) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, today announced that Paul Levesque,...

THERF : 3.8000 (+4.68%)
TH.TO : 4.48 (-2.82%)
THTX : 3.52 (-2.49%)
Theratechnologies Establishes New At-The-Market Facility

COMTEX_390317604/2669/2021-07-23T19:31:10

THERF : 3.8000 (+4.68%)
TH.TO : 4.48 (-2.82%)
THTX : 3.52 (-2.49%)
Theratechnologies Reports Financial Results for the Second Quarter of Fiscal 2021 and Provides Update on Its Planned Phase 3 Clinical Trial in NASH

Theratechnologies, Inc. (Theratechnologies, or Company) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, today reported financial...

THERF : 3.8000 (+4.68%)
TH.TO : 4.48 (-2.82%)
THTX : 3.52 (-2.49%)
Canadian Investors Point to Jobs Data Next Week

Monday U.S. U.S. markets closed for Independence Day Tuesday U.S. Economic Lookahead Markit ...

TV.TO : 0.1700 (-5.56%)
TH.TO : 4.48 (-2.82%)
RCH.TO : 44.60 (-1.98%)
TV : 12.01 (-3.77%)
SGH : 47.97 (-1.66%)
MSM : 78.96 (+0.22%)
FIZZ : 51.97 (-0.48%)
WDFC : 223.62 (-1.66%)
KALV : 17.95 (-6.75%)
LEVI : 24.42 (-3.82%)
HELE : 229.52 (-1.91%)
ACCD : 43.60 (-3.99%)
GBX : 41.35 (-1.22%)
AZZ : 51.21 (-1.02%)
CORRECTION: Theratechnologies to Announce Financial Results for Its Second Quarter Fiscal 2021

In a release issued this morning, Wednesday, June 30, 2021, under the same headline, by Theratechnologies Inc. (TSX: TH) (NASDAQ: THTX), please note that in the last sentence of the first paragraph, the...

THERF : 3.8000 (+4.68%)
TH.TO : 4.48 (-2.82%)
THTX : 3.52 (-2.49%)
Theratechnologies to Announce Financial Results for Its Second Quarter Fiscal 2021

Theratechnologies Inc. (TSX: TH) (NASDAQ: THTX) (Theratechnologies), a biopharmaceutical company focused on the development and commercialization of innovative therapies announced today that it will report...

THERF : 3.8000 (+4.68%)
TH.TO : 4.48 (-2.82%)
THTX : 3.52 (-2.49%)
Theratechnologies Appoints New Board Member

Theratechnologies Inc. (Theratechnologies) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, today announced the appointment...

THERF : 3.8000 (+4.68%)
TH.TO : 4.48 (-2.82%)
THTX : 3.52 (-2.49%)
Theratechnologies Announces New Preclinical Findings for Its Lead Investigational Peptide-Drug Conjugate TH1902 for the Potential Treatment of Metastatic Cancers

Demonstrates better anti-metastatic activity compared with docetaxel alone

TH.TO : 4.48 (-2.82%)
THTX : 3.52 (-2.49%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Key Turning Points

3rd Resistance Point 4.72
2nd Resistance Point 4.66
1st Resistance Point 4.57
Last Price 4.48
1st Support Level 4.42
2nd Support Level 4.36
3rd Support Level 4.27

See More

52-Week High 5.34
Last Price 4.48
Fibonacci 61.8% 4.23
Fibonacci 50% 3.89
Fibonacci 38.2% 3.54
52-Week Low 2.43

See More

Business Summary

Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. The company mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization...

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar